This website is intended for journalists outside the US/UK/Canada, who are interested in media information from Boehringer Ingelheim.

Top Stories



    ERS 2015 International Congress


    EMPA-REG OUTCOME(R) results were at EASD

    Events and Initiatives

    European Cancer Congress 2015

    21 September 2015

    Education Hub




    Nintedanib* Lume-Lung
    1 Clinical Trial


    Afatinib* Lux-Lung 3 & 6
    Clinical Trials

    Tweets from @Boehringer